Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -0.887M
March 31, 2026 -1.142M
December 31, 2025 -0.934M
September 30, 2025 -3.422M
June 30, 2025 -2.602M
March 31, 2025 -1.598M
December 31, 2024 -0.845M
September 30, 2024 -0.449M
June 30, 2024 -1.166M
March 31, 2024 -0.45M
December 31, 2023 -0.816M
September 30, 2023 -1.412M
June 30, 2023 -4.811M
March 31, 2023 -3.318M
December 31, 2022 -7.276M
September 30, 2022 -6.548M
June 30, 2022 -9.082M
March 31, 2022 -13.27M
Date Value
December 31, 2021 -14.14M
September 30, 2021 4.804M
June 30, 2021 -11.42M
March 31, 2021 -15.03M
December 31, 2020 -11.90M
September 30, 2020 -8.627M
June 30, 2020 -13.49M
March 31, 2020 -8.424M
December 31, 2019 14.71M
September 30, 2019 -5.365M
June 30, 2019 -5.09M
March 31, 2019 -4.02M
December 31, 2018 -5.992M
September 30, 2018 -4.198M
June 30, 2018 -4.744M
March 31, 2018 -4.647M
December 31, 2017 -5.542M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. -14.15M
Century Therapeutics, Inc. -20.53M
Absci Corp. -27.56M
Celularity, Inc. 1.447M
Cardio Diagnostics Holdings, Inc. -1.389M